← FDA DRUG APPROVALS

FDA ANDA · ANDA074740

ATRACURIUM BESYLATE

Sponsor: HOSPIRA

APPLICATION
ANDA074740
TYPE
ANDA
ORIGINAL APPROVAL
1997-03-28
LATEST ACTION
2003-01-28
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ATRACURIUM BESYLATEDiscontinued
ATRACURIUM BESYLATE 10MG/ML · INJECTABLE · INJECTION

Approval history

2003-01-28Labeling · Supplement 13AP
2000-04-28Manufacturing (CMC) · Supplement 11AP
1999-06-18Manufacturing (CMC) · Supplement 10AP
1998-09-04Manufacturing (CMC) · Supplement 8AP
1998-09-04Manufacturing (CMC) · Supplement 9AP
1998-05-06Labeling · Supplement 3AP
1997-06-19Manufacturing (CMC) · Supplement 2AP
1997-06-19Manufacturing (CMC) · Supplement 1AP
1997-03-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →